# Tepezza (teprotumumab) and hearing loss side effects

> Why the thyroid eye disease drug has been linked to sudden hearing loss and tinnitus.

**Canonical URL:** https://drugsmonitor.com/guides/tepezza-hearing-loss
**Last updated:** 2026-06-11

Tepezza (teprotumumab) is the first FDA-approved drug for thyroid eye disease. Post-market surveillance has revealed significant reports of hearing-related side effects including sudden sensorineural hearing loss, tinnitus, and hyperacusis.

Some patients have reported permanent hearing damage that significantly affects daily life. The FDA updated the prescribing label to include these risks, but plaintiffs argue that earlier and stronger warnings were needed.

If you received Tepezza infusions and experienced hearing loss, ringing in the ears, or sound sensitivity, see an audiologist for baseline testing and consult with counsel about your legal options.

---

*Educational guide from DrugsMonitor.com. Not legal advice.*